For a limited time, Wegovy will be available to new patients at $199 for the first month, Novo Nordisk said Thursday.

Inadequate supply has created opportunities for bad actors seeking to profit from shortages, high costs and demand ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...

Starting today, pharmacies can no longer make cheaper alternatives to popular weight loss drugs, driving up costs for ...

Novo Nordisk reduces its starter dose prices through telehealth platforms to encourage weaning patients off compounded copycats.